Another study assessed the levels of C-reactive protein (CRP), antimicrobial antibodies, autoantibodies (such as IgA-, IgM-, and IgG-class rheumatoid factors (RF)), and antibodies to cyclic citrullinated peptide (anti-CCP) in 22 patients with RA treated with RTX. This evidence concerns the gene CRP and rheumatoid arthritis.